ANI Pharmaceuticals Inc’s filing revealed that its SR. VP, GENERAL COUNSEL & SEC. Cook Meredith unloaded Company’s shares for reported $27584.0 on Apr 14 ’25. In the deal valued at $68.96 per share,400 shares were sold. As a result of this transaction, Cook Meredith now holds 80,145 shares worth roughly $5.67 million.
Then, Davis Krista sold 1,866 shares, generating $121,290 in total proceeds. Upon selling the shares at $65.00, the SVP, CHIEF HR OFFICER now owns 64,659 shares.
Before that, Cook Meredith sold 400 shares. ANI Pharmaceuticals Inc shares valued at $25,332 were divested by the SR. VP, GENERAL COUNSEL & SEC. at a price of $63.33 per share. As a result of the transaction, Cook Meredith now holds 80,545 shares, worth roughly $5.7 million.
Jefferies initiated its ANI Pharmaceuticals Inc [ANIP] rating to a Buy in a research note published on March 14, 2025; the price target was $80. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Leerink Partners began covering ANIP with “an Outperform” recommendation on December 11, 2024. Piper Sandler started covering the stock on October 11, 2024. It rated ANIP as “an Overweight”.
Price Performance Review of ANIP
On Monday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock jump 1.33% to $70.75. Over the last five days, the stock has gained 4.04%. ANI Pharmaceuticals Inc shares have risen nearly 27.98% since the year began. Nevertheless, the stocks have risen 8.13% over the past one year. While a 52-week high of $70.55 was reached on 04/28/25, a 52-week low of $52.50 was recorded on 01/13/25. SMA at 50 days reached $64.05, while 200 days put it at $60.11.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 69.15, which if violated will result in even more drops to 67.55. On the upside, there is a resistance level at 72.10. A further resistance level may holdings at 73.45. The Relative Strength Index (RSI) on the 14-day chart is 62.81, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.89, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 10.56%. Stochastics %K at 90.72% indicates the stock is a selling.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2025-04-15, dropping by -0.22 million shares to a total of 2.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 2.58 million shares. There was a decline of -9.48%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 15, 2024 when CapitalOne began covering the stock and recommended ‘”an Overweight”‘ rating along with a $80 price target.
